Click the star to add/remove an item to/from your individual schedule.
You need to be logged in to avail of this functionality.
Log in
Accepted Paper:
Afrolongevity: Biomedicine And Biotech Revolution In Africa.
Osinakachi Akuma Kalu
(TAFFD's)
Kgomotsego Brenda Ramokopelwa
(TAFFD’s)
Paper short abstract:
Afrolongevity seeks to explore biotechnology and biomedical approaches that work for Africans in the treatment of ageing and age-related diseases to bridge life expectancy gaps for healthy living in Africa.
Paper long abstract:
At the twilight of the 21st Century, Transhumanism's manifesto echoes - super intelligence, "super-longevity," and "super well-being", forming the pillars of the movement and setting the pace for the future of humankind, which starts now. A recent report by Statista stated that "for Africans born in 2021, their average life expectancy at birth across Africa was 63 years for males and 66 years for females" when the average life expectancy globally was 71 years for males and 75 years for females in mid-2021 which raises significant concern about the future of Africa. Thus, there is a need to improve the quality of life and close the life expectancy gaps in the continent through the lens of Afrolongevity. Afrolongevity is a concept that describes people of African descent living longer using advanced technologies, precision, and intervention medicines to crusade ageing and age-related disease. It advocates the need for ageing/epigenetic clocks in clinics so that people can regulate their ageing as it's been done with other diseases for an improved health span. The place of advanced biomedicines and biotechnologies in improving the quality of life of Africans who are affected by ageing and its related conditions is what this paper seeks to address with the aim of closing the life expectancy gaps in the continent.